SPAG9 and endocervical adenocarcinoma: Stage wise distribution of SPAG9 was analyzed in 281 samples of cervical squamous cell carcinoma and endocervical adenocarcinoma (CESC) from the cancer genome atlas data (TCGA; Fig. 1f).